Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Certifies Empire Genomics, Welgene for Microarray Service Providers Program

NEW YORK (GenomeWeb News) — Agilent Technologies said yesterday it has signed on Empire Genomics and Welgene Biotech as new members of its Certified Microarray Service Providers program.
 
The program includes training and assessments with Agilent’s 60-mer oligo microarrays, the company said. The training systems for the Agilent platforms include quality control, sample preparation, hybridization, microarray analysis, and final data analysis.  
 
Empire Genomics is a personalized medicine company based in Buffalo, NY, and Welgene Biotech is a PCR and microarray-analysis company based in Taipei City, Taiwan.
 
Agilent also said it re-certified French RNA-splicing company ExonHit.
 
 

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.